Researchers from Drexel University reversed symptoms of Alzheimer’s disease in fruit flies by restoring the balance between two epigenetic enzymes that regulate gene expression, a study shows.
Early in the progression of Alzheimer’s disease, cognitive impairment (such as difficulties with learning and memory) may be tied to the presence of elevated levels of the HDAC2 enzyme. HDAC2 helps control how genes linked to learning and memory are expressed. It appears that when HDAC2 overwhelms the enzyme it is paired with, which is called Tip60 HAT, it represses genes and leads to problems with neuroplasticity — the brain’s ability to adapt to new stimuli or recall reactions to stimuli it already encountered.
But a research team led by Priyalakshmi Panikker, a PhD student, and Felice Elefant, PhD, an associate professor, both in Drexel’s College of Arts and Sciences, performed tests in flies and found that if they added extra Tip60 HAT in the brain of flies that displayed symptoms close to Alzheimer’s disease, the balance between the enzymes could be successfully restored. When that balance came back, behaviors the team had taught the flies were able to be learned again and remembered.
“Our findings strongly support the concept of exploring the efficacy of specific Tip60 HAT activators, as well as identifying and manipulating additionally misregulated Tip60 target genes,” Elefant said.
Elefant, Panikker and their team — whose findings were published in the Journal of Neuroscience — looked at how Alzheimer’s disease affected flies early in their development, during their larval stages, to catch what might happen in Alzheimer’s well before the tell-tale symptoms arise.
“Many researchers that study Alzheimer’s disease utilize human post-mortem samples, and thus, they are not looking at what is happening during the early progression of neurodegeneration, including whether we can correctwhat is happening during these early stages ,” Elefant said.
For the study, flies were taught to associate a certain odor with sucrose — table sugar, which flies eat and is a positive reinforcement. After being exposed to the scent paired with sugar, the flies learned to move towards the scent even without the sugar present.
Flies that modeled Alzheimer’s disease showed no difference in their reaction to the smell they had earlier been condition to. This showed that their ability to learn and remember this association was negatively affected.
But once Tip60 HAT was introduced in the brain to correct the identified Tip60 HAT/HDAC2 imbalance, these flies showed a reaction time comparable to the ones without the Alzheimer’s type of condition. This indicated that they recovered their ability to learn and remember after the epigenetic balance was reintroduced.
Moreover, when researchers identified a collection of genes related to brain function that had been repressed in the flies — due to elevated HDAC2 — an introduction of increased Tip60 HAT levels in the brain restored regular function in 9 of the 11 genes tested.
The results Panikker and Elefant found were encouraging. More testing is needed, but Elefant’s goal is to find new avenues for gene therapy.
“When people age, they have a loss of memory but it’s not because there are mutations in their genes,” Elefant said. “It’s the way they’re packaged. They’re distorted. And we’re seeing non-invasive ways we might be able to prevent that early on.”
Those interested in reading the full study, “Restoring Tip60 HAT/HDAC2 balance in the neurodegenerative brain relieves epigenetic transcriptional repression and reinstates cognition,” can access it here.
The Latest on: Alzheimer’s disease
[google_news title=”” keyword=”Alzheimer’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Alzheimer’s disease
- Trouble with spatial navigation could be sign of Alzheimer'son February 29, 2024 at 7:19 am
Middle-aged folks who have difficulties navigating their way through space could be at higher risk of developing Alzheimer's disease years later, a new study finds.
- PharmaKure announces epigenetics collaboration with Sheffield Hallam University to understand mechanisms of Alzheimer’s Diseaseson February 29, 2024 at 6:50 am
PharmaKure , a clinical stage pharmaceutical company developing precision medicines for Alzheimer’s Disease and other neurodegenerative diseases, today announces a new epigenetics collaboration with ...
- Alamar Biosciences and ALZpath, Inc. Announce Strategic Supply Agreement for pTau217 Antibody to Advance Alzheimer's Disease Researchon February 29, 2024 at 6:12 am
The focal point of this partnership is the ALZpath pTau217 (phosphorylated tau at position 217) antibody, a crucial tool in the investigation of Alzheimer's disease and various other neurodegenerative ...
- Study links air pollution to increased Alzheimer's riskon February 29, 2024 at 5:17 am
If you live in Alabama, Georgia, California, Pennsylvania, Missouri, Texas, Indiana, or Illinois, stop what you’re doing and recite the names of 12 types o ...
- Poor spatial navigation could predict Alzheimer's disease years before the onset of symptomson February 29, 2024 at 4:00 am
People at risk of Alzheimer's disease have impaired spatial navigation prior to problems with other cognitive functions, including memory, finds a new study led by UCL researchers.
- Flickering Light Can Slow Alzheimer's Disease, MIT Scientists Sayon February 28, 2024 at 8:00 am
Hope may be in sight for millions of Alzheimer's patients as scientists have found a way to slow disease progression and treat its symptoms using only light and sound. Alzheimer's affects roughly 5.8 ...
- Researchers make precious headway into a genetic form of Alzheimer's diseaseon February 27, 2024 at 12:49 pm
UC Santa Barbara researchers and collaborators in Colombia, Brazil and Germany are progressing toward an understanding of mechanisms that underlie Alzheimer's disease, in particular an early-onset, ...
- Possible Alzheimer's disease treatment breakthrough: UNC researchers focus on amyloid plaqueon February 27, 2024 at 7:01 am
CHAPEL HILL, N.C. (WTVD) -- A research team at UNC is studying how amyloid plaque forms in the brain of Alzheimer's patients in hopes of developing breakthrough treatments for the disease. "When we ...
- University of Pittsburgh asks for volunteers for Alzheimer's disease studyon February 26, 2024 at 7:57 pm
PITTSBURGH (KDKA) — There's currently no way to stop Alzheimer's disease, but people across the world and in the Pittsburgh area collaborating on a study around one drug in hopes of finding a way to ...
via Bing News